Financhill
Back

Ocuphire Pharma 10K Form

Sell
33

OCUP
Ocuphire Pharma

Last Price:
1.35
Seasonality Move:
-20.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OCUP News And Ratings

See the #1 stock for the next 7 days that we like better than OCUP

OCUP Financial Statistics

Sales & Book Value

Annual Sales: $19.05M
Cash Flow: $-7.29M
Price / Cash Flow: 0
Annual Sales: $1.56
Price / Book: 0.84

Profitability

EPS (TTM): -0.55000
Net Income (TTM): $-14.11M
Gross Margin: --
Return on Equity: -31.4%
Return on Assets: -28.41%

Ocuphire Pharma Earnings Forecast

Key Ocuphire Pharma Financial Ratios

  • The Research & Development expenses have been 92.67% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of OCUP is -52.42% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Ocuphire Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: OCUP
CUSIP: 67577R
Website: ocuphire.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 10.68
Quick Ratio: 10.41

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 1.69

OCUP Technical Analysis vs Fundamental Analysis

Sell
33
Ocuphire Pharma (OCUP) is a Sell

Is Ocuphire Pharma a Buy or a Sell?

  • Ocuphire Pharma stock is rated a Sell
    The current Ocuphire Pharma [OCUP] share price is $1.31. The Score for OCUP is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.